Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DAVID HU who wrote (8)	7/17/1996 10:33:00 AM
From: DAVID HU	of 496

More news on Glfd. Group holds 5.3 percent Guilford Pharmaceuticals Inc stake WASHINGTON, July 16 (Reuter) - A group of investment advisers including Deerfield Capital L.P. of New York said Tuesday it has acquired a 5.3 percent stake in Guilford Pharmaceuticals Inc. In a filing with the Securities and Exchange Commission, the group said it paid $11.7 million for the stake and holds it for investment purposes. It said its latest transactions include the net purchase of 250,000 common shares bought from June 3 through July 12 at prices ranging from $20.42 to $34.25 per share. Guildford is Baltimore, Md-based pharmaceutical company specializing in drugs used for the treatment of nervous system disorders.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next